Results 191 to 200 of about 414,434 (222)

ASCOT-LLA: ¿estatinas en la hipertensión?

Clínica e Investigación en Arteriosclerosis, 2004
J.A. Arnaiz, X. Carné
openaire   +1 more source

The LLA protests

Academic Questions, 1994
openaire   +1 more source

Association of two silent polymorphisms of platelet glycoprotein la/lla receptor with risk of myocardial infarction: a case-control study

Lancet, The, 1999
Bernhard Lämmle
exaly  

(5.lla)

2018
openaire   +1 more source

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Lancet, The, 2003
Mark J Caulfield, Jesper Mehlsen, Jan Östergren   +2 more
exaly  

LLA on the Move!

Talking Points
Yang Wang, Patricia C. Paugh, Sherry Sanden   +2 more
openaire   +1 more source

“SIA AKKA/LLA v. LATVIA”

IIC - International Review of Intellectual Property and Competition Law, 2017
openaire   +1 more source

Degradation of electrospun SF/P(LLA-CL) blended nanofibrous scaffolds in vitro

Polymer Degradation and Stability, 2011
Kuihua Zhang, Chen Huang, Xiu-Mei Mo
exaly  

III . —Lla réadmission

2010
openaire   +1 more source

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

Lancet, The, 2017
David Thompson, Andrew J O Whitehouse, Neil R Poulter   +2 more
exaly